Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Horiguchi, Hironori; Yamamoto, Kazuyoshi; Kishi, Toshiaki; Otake, Shinichi*; Kumada, Hiroaki*
JAEA-Research 2009-015, 38 Pages, 2009/07
JAEA-Research-2009-015.pdf:7.61MB
The boron neutron capture therapy (BNCT) has been conducted at JRR-4. There is an increased number of cases due to the expansion of application against head and neck cancer and skin cancer. Therefore, the BNCT requires the establishment of procedure to perform more cases in a day. The determination of boron concentration in blood is important to determine the prescribed dose given to a patient. Currently, prompt 
ray analysis (PGA) is applied to the determination of boron concentration. But the PGA is not applied to more than three times BNCT a day. Therefore, swiftness and precision method by inductively coupled plasma atomic emission spectrometry (ICP-AES) is studied. Using BSH for Boron standard of the ICP-AES, we enabled to analyze accurately without an intricate sample preparation. The measurement precision of the ICP-AES was within 5% by the correction factor based on the PGA. We established the method of swiftness determination of boron concentration in blood for BNCT.
Shibata, Yasushi*; Matsumura, Akira*; Yamamoto, Tetsuya*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Nakai, Kei*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; et al.
Research and Development in Neutron Capture Therapy, p.1055 - 1060, 2002/09
We prospectively investigated the predictability of blood boron concentrations using the data obtained at the first craniotomy after infusion of a low dose of sodium undecahydroclosododecaborate (BSH). Nine patients with malignant glial tumors underwent Boron neutron capture therapy (BNCT) at the Japan Atomic Energy Research Institute (JAERI) between 1995 and 2001. In 7 patients, 1g of BSH was infused before the first tumor removal and boron concentrations were determined using prompt gamma ray analysis (PGA). Then, 12 hours before BNCT, patients were infused at a dose of 100mg/kg BSH, and the boron concentrations were determined again. The boron biodistribution data showed a biexponential pharmacokinetic profile. If the final boron concentration at 6 or 9 hours after the end of the infusion is within the 95% confidence interval of the prediction, direct prediction from biexponential fit will reduce the error of blood boron concentrations during irradiation to around 6%.
Endo, Kiyoshi*; Matsumura, Akira*; Yamamoto, Tetsuya*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Kishi, Toshiaki; Torii, Yoshiya; Kashimura, Takanori*; Otake, Shinichi*
Research and Development in Neutron Capture Therapy, p.425 - 430, 2002/09
Using the Rapid Prototyping Technique, we produced a realistic phantom as a formative model of a patient head. This realistic phantom will contribute to verification of our planning system. However, cross-correlation among the calculations using the JAERI Computational Dosimetry System (JCDS), the realistic phantom, and the in vivo measurements were not fully completed because of the difficulty involved in modeling a post-surgical brain and a thermal neutron shield. The experimental simulation technique using the realistic phantom is a useful tool for more reliable dose planning for the intraoperative BNCT.
Matsushita, Akira*; Yamamoto, Tetsuya*; Matsumura, Akira*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Torii, Yoshiya; Kashimura, Takanori*; Otake, Shinichi*
Research and Development in Neutron Capture Therapy, p.141 - 143, 2002/09
A thermal-epithermal mixed beam "Thermal Neutron Beam Mode I" was used in the eleven sessions of boron neutron capture therapy which have been performed at JRR-4 from 1998. We are planning to use an epithermal beam for the treatment of deeper tumors in the next trial of the intraoperative BNCT. In this study, "Epi-12" which was made by putting up a cadmium shutter of "Thermal Neutron Beam Mode I" was investigated for the clinical benefits and safety by epithermal beams. Decrease of fast neutron contamination ratio in Epi-12 mode is the advantage for BNCT, particular in the intraoperative BNCT. Because fast neutron on the brain surface is one of the critical factors in the intraoperative BNCT in which the plain beam directly interacts the normal structures. Furthermore a mixture of mode Epi-12 and Th-12 will provide various dose distribution designs. It may be used as a new method to control the best distribution for individual tumors.
Yamamoto, Kazuyoshi; Kumada, Hiroaki; Torii, Yoshiya; Hori, Naohiko; Kishi, Toshiaki; Takada, Juntaro*; Otake, S.*
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.243 - 244, 2000/10
no abstracts in English
Shibata, Yasushi*; Matsumura, Akira*; Yamamoto, Tetsuya*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Nakai, K.*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; et al.
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.145 - 146, 2000/10
no abstracts in English
*; Mizuta, H.; *; *; Hirasawa, Masayoshi; *; Uruwashi, Shinichi*
PNC TN841 75-03, 203 Pages, 1975/01
no abstracts in English